FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
A quick guide outlining which cryptocurrency to buy first, focusing on accessibility, liquidity, and practical use cases for newcomers.
24,236 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
The Senate delivers a bipartisan win with the ROAD to Housing Act, yet observers say the measure only scratches the s...
Investors are buzzing about Oklo as the Aurora Powerhouse regulatory path becomes clearer. This piece breaks down wha...
A new study identifies which sectors most often spawn 100-bagger stocks, challenging tech dominance. It highlights re...
Andrej Karpathy, a founding member of OpenAI, has moved to Anthropic, marking a pivotal leadership shift in the AI ra...
XRP eased lower toward a critical support level as sellers held sway, signaling thinning upside momentum for the near...
Cypherpunk Technologies reaffirms a 5% ZEC reserve despite a patched Zcash flaw, as investors debate the strategy ami...
Celebrity headlines grab attention, but the real story is how money moves in the face of uncertainty. This guide tran...
In Q1 2026, Duquesne Family Office quietly expanded its South American equity bets, signaling a macro-led stance that...
SpaceX remains privately held, but chatter about a public listing fuels the myth that a superstar IPO will power the ...
Stryker and Intuitive Surgical reported divergent Q1 2026 results, underscoring two distinct medtech playbooks. Stryk...
In crypto analytics, cost and speed matter as much as accuracy. A perplexity fine-tuned chinese model offers a breakt...